Skip to main content

Table 2 Effect of YGMM on ALT, AST, TG and TB levels in control and alcohol-treated rats

From: Evaluation of the hepatoprotective effect of Yigan mingmu oral liquid against acute alcohol-induced liver injury in rats

Group

ALT (U/l)

AST (U/l)

TG (mg/dl)

TB (mg/dl)

AST/ALT

Control

8.49 ± 0.33

21.70 ± 1.10

3.75 ± 0.56

0.28 ± 0.02

2.57 ± 0.15

Alcohol

11.37 ± 0.37##

31.28 ± 1.95###

10.50 ± 2.14##

0.47 ± 0.04###

2.77 ± 0.23

Silymarin

8.09 ± 0.47**

24.16 ± 3.56*

2.67 ± 0.61***

0.32 ± 0.03**

3.03 ± 0.55

YGMM (low dose)

9.35 ± 1.12

22.24 ± 2.23**

3.08 ± 1.09**

0.33 ± 0.03**

2.41 ± 0.13

YGMM (medium dose)

8.34 ± 1.44*

19.79 ± 0.58***

4.77 ± 1.42*

0.26 ± 0.06***

2.52 ± 0.43

YGMM (high dose)

8.56 ± 0.41*

18.50 ± 1.88***

4.89 ± 1.80*

0.26 ± 0.01***

2.15 ± 0.14

  1. Data are presented as mean ± SEM in each group. Statistically significant differences are indicated by asterisks and pound sign (*p < 0.05, **p < 0.01, ***p < 0.001 compared with the model group; ##p < 0.01, ###p < 0.001 compared with the control group)